Lung resection and immunotherapy: two allied for a new hope in lung cancer cure

Bertrand Mennecier¹, Anne Olland^{2

3

4}, Gilbert Massard^{2

3

4}, Pierre-Emmanuel Falcoz^{2

3

4}

Affiliations

¹ Thoracic Pathology Department, Pulmonology Unit, University Hospital, Strasbourg, France.
² INSERM (French National Institute of Health and Medical Research), UMR 1260, Regenerative Nanomedicine (RNM), FMTS, Strasbourg, France.
³ Université de Strasbourg, Faculté de médecine et pharmacie, Strasbourg, France.
⁴ Hôpitaux Universitaire de Strasbourg, Service de chirurgie thoracique - Nouvel Hôpital Civil, Strasbourg, France.

Editorial

Bertrand Mennecier et al. J Thorac Dis. 2018 Nov.

. 2018 Nov;10(Suppl 33):S4168-S4169.

doi: 10.21037/jtd.2018.10.93.

Bertrand Mennecier¹, Anne Olland^{2

3

4}, Gilbert Massard^{2

3

4}, Pierre-Emmanuel Falcoz^{2

3

4}

¹ Thoracic Pathology Department, Pulmonology Unit, University Hospital, Strasbourg, France.
² INSERM (French National Institute of Health and Medical Research), UMR 1260, Regenerative Nanomedicine (RNM), FMTS, Strasbourg, France.
³ Université de Strasbourg, Faculté de médecine et pharmacie, Strasbourg, France.
⁴ Hôpitaux Universitaire de Strasbourg, Service de chirurgie thoracique - Nouvel Hôpital Civil, Strasbourg, France.

No abstract available

Conflict of interest statement

Conflicts of Interest: The authors have no conflicts of interest to declare.

Safety and Feasibility of Lung Resection After Immunotherapy for Metastatic or Unresectable Tumors.
Bott MJ, Cools-Lartigue J, Tan KS, Dycoco J, Bains MS, Downey RJ, Huang J, Isbell JM, Molena D, Park BJ, Rusch VW, Sihag S, Jones DR, Adusumilli PS. Bott MJ, et al. Ann Thorac Surg. 2018 Jul;106(1):178-183. doi: 10.1016/j.athoracsur.2018.02.030. Epub 2018 Mar 14. Ann Thorac Surg. 2018. PMID: 29550207 Free PMC article.

1. Bott MJ, Cools-Lartigue J, Tan KS, et al. Safety and Feasibility of Lung Resection After Immunotherapy for Metastatic or Unresectable Tumors. Ann Thorac Surg 2018;106:178-83. 10.1016/j.athoracsur.2018.02.030 - DOI - PMC - PubMed
1. Provencio M, Nadal E, Insa A, et al. WCLC 2018. AbstOA01.05. Available online: https://library.iaslc.org/conference-program?product_id=10&author=&categ...
1. Forde PM, Chaft JE, Pardoll DM. Neoadjuvant PD-1 Blockade in Resectable Lung Cancer. N Engl J Med 2018;379:e14. 10.1056/NEJMc1808251 - DOI - PubMed
1. Pataer A, Kalhor N, Correa AM, et al. Histopathologic response criteria predict survival of patients with resected lung cancer after neoadjuvant chemotherapy. J Thorac Oncol 2012;7:825-32. 10.1097/JTO.0b013e318247504a - DOI - PMC - PubMed
1. Fournel L, Falcoz PE, Mansuet-Lupo A, et al. A bicenter study on adjuvant surgery following treatment with tyrosine kinase inhibitors in patients with advanced lung adenocarcinoma. Interact Cardiovasc Thorac Surg 2018;27:598-601. 10.1093/icvts/ivy120 - DOI - PubMed